Latest
Roquefort Therapeutics is a LSE Main Market listed biotech company developing first in class drugs in the high value and high growth oncology segment prior to partnering or selling to big pharma. Since listing in March 2021, Roquefort Therapeutics has successfully acquired Lyramid Pty Limited, a leader in the development of medicines for a new therapeutic target, Midkine (a human growth factor associated with cancer progression), and most recently acquired Oncogeni Ltd, founded by Nobel Laureate Professor Sir Martin Evans, which has developed two families of innovative cell and RNA oncology medicines.
When we talk of Natural disasters, there is no way to prevent them. There is no ruling over Mother Nature. The best one can do is to be...
Work culture changed in Australia during the COVID-19 pandemic. Over 40% of Australians worked from home during the first half of 2021....
Calima Energy Limited (ASX: CE1 / OTCQB: CLMEF) (“Calima” or the “Company”) is ready to take advantage of growing energy...